Literature DB >> 9683358

Testing for mutations of the ataxia telangiectasia gene in radiosensitive breast cancer patients.

J Ramsay1, G Birrell, M Lavin.   

Abstract

BACKGROUND AND
PURPOSE: To determine if clinical radiosensitivity in breast cancer patients is related to mutations of the ataxia telangiectasia gene (ATM).
MATERIALS AND METHODS: Fifteen patients who had developed a severe late reaction to a standard radiotherapy schedule were examined for evidence of increased in vitro radiosensitivity using the MTT assay. Mutation analysis was performed using a protein truncation assay.
RESULTS: No mutations were detected in the 15 patients despite evidence of increased in vitro radiosensitivity.
CONCLUSIONS: Testing for the ATM gene is unlikely to be useful for predicting clinical response to radiotherapy in breast cancer patients.

Entities:  

Mesh:

Year:  1998        PMID: 9683358     DOI: 10.1016/s0167-8140(98)00014-0

Source DB:  PubMed          Journal:  Radiother Oncol        ISSN: 0167-8140            Impact factor:   6.280


  7 in total

1.  Low levels of ATM in breast cancer patients with clinical radiosensitivity.

Authors:  Zhiming Fang; Sergei Kozlov; Michael J McKay; Rick Woods; Geoff Birrell; Carl N Sprung; Dédée F Murrell; Kiran Wangoo; Linda Teng; John H Kearsley; Martin F Lavin; Peter H Graham; Raymond A Clarke
Journal:  Genome Integr       Date:  2010-06-24

2.  Rare, evolutionarily unlikely missense substitutions in ATM confer increased risk of breast cancer.

Authors:  Sean V Tavtigian; Peter J Oefner; Davit Babikyan; Anne Hartmann; Sue Healey; Florence Le Calvez-Kelm; Fabienne Lesueur; Graham B Byrnes; Shu-Chun Chuang; Nathalie Forey; Corinna Feuchtinger; Lydie Gioia; Janet Hall; Mia Hashibe; Barbara Herte; Sandrine McKay-Chopin; Alun Thomas; Maxime P Vallée; Catherine Voegele; Penelope M Webb; David C Whiteman; Suleeporn Sangrajrang; John L Hopper; Melissa C Southey; Irene L Andrulis; Esther M John; Georgia Chenevix-Trench
Journal:  Am J Hum Genet       Date:  2009-09-24       Impact factor: 11.025

3.  Toxicity from radiation therapy associated with abnormal transcriptional responses to DNA damage.

Authors:  Kerri E Rieger; Wan-Jen Hong; Virginia Goss Tusher; Jean Tang; Robert Tibshirani; Gilbert Chu
Journal:  Proc Natl Acad Sci U S A       Date:  2004-04-19       Impact factor: 11.205

4.  ATM gene mutations in sporadic breast cancer patients from Brazil.

Authors:  Flavia Rotea Mangone; Elisabete C Miracca; Harriet E Feilotter; Lois M Mulligan; Maria Aparecida Nagai
Journal:  Springerplus       Date:  2015-01-15

5.  Assessment of Radiation Induced Therapeutic Effect and Cytotoxicity in Cancer Patients Based on Transcriptomic Profiling.

Authors:  Sajjad Karim; Zeenat Mirza; Adeel G Chaudhary; Adel M Abuzenadah; Mamdooh Gari; Mohammed H Al-Qahtani
Journal:  Int J Mol Sci       Date:  2016-02-19       Impact factor: 5.923

6.  Radiation-hypersensitive cancer patients do not manifest protein expression abnormalities in components of the nonhomologous end-joining (NHEJ) pathway.

Authors:  T Leong; M Chao; S Bassal; M McKay
Journal:  Br J Cancer       Date:  2003-04-22       Impact factor: 7.640

7.  Severe reaction to radiotherapy provoked by hypomorphic germline mutations in ATM (ataxia-telangiectasia mutated gene).

Authors:  Reza Asadollahi; Christian Britschgi; Pascal Joset; Beatrice Oneda; Detlev Schindler; Urs R Meier; Anita Rauch
Journal:  Mol Genet Genomic Med       Date:  2020-08-03       Impact factor: 2.183

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.